Aggarwal Multy Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-01-2025
- Paid Up Capital ₹ 1.00 M
as on 14-01-2025
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -12.36%
(FY 2020)
- Profit -68.69%
(FY 2020)
- Ebitda -82.00%
(FY 2020)
- Net Worth 11.53%
(FY 2020)
- Total Assets 19.29%
(FY 2020)
About Aggarwal Multy Speciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Binod Mukta, Dilip Kumar, Ranjeet Verma, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74140DL2015PTC284319
- Company No.
284319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aggarwal Multy Speciality Hospital?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binod Mukta  | Director | 20-Aug-2015 | Current |
| Dilip Kumar | Additional Director | 20-Sep-2015 | Current |
| Ranjeet Verma | Director | 20-Aug-2015 | Current |
| Kumari Sinha | Director | 20-Aug-2015 | Current |
| Mohan Gupta | Director | 20-Aug-2015 | Current |
| Amrendra Kumar | Director | 20-Aug-2015 | Current |
Financial Performance of Aggarwal Multy Speciality Hospital.
Aggarwal Multy Speciality Hospital Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.36% decrease. The company also saw a substantial fall in profitability, with a 68.69% decrease in profit. The company's net worth Soared by an impressive increase of 11.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aggarwal Multy Speciality Hospital?
In 2020, Aggarwal Multy Speciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aggarwal Multy Speciality Hospital?
Unlock and access historical data on people associated with Aggarwal Multy Speciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aggarwal Multy Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aggarwal Multy Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.